Background
Hypertension affects about 1/3 of adults worldwide, ~3.8 million in Taiwan, 160 million in China, and 1 billion worldwide. It is a major risk factor leading to stroke, cardiovascular disease, and end-stage renal disease. In each year, more than 13.5 million deaths are due to hypertension-related diseases worldwide.
Methods
We performed a two-stage association study of hypertension using genotype data of single-nucleotide polymorphisms (SNPs) from 992 young-onset hypertensive cases and 992 matched controls of Han Chinese in Taiwan. A total of 238 SNPs of 36 highly replicated hypertension candidate genes with functional importance were investigated. Association analysis was carried out using conditional logistic regression.
results
We identified two SNPs that were strongly associated with hypertension in both the first and the second stages. The first SNP (rs2301339) is located at guanine nucleotide-binding protein β3 subunit (GNB3) and the other one (rs17254521) is located at insulin receptor (INSR).
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Hypertensive Candidate Genes in Han Chinese examined using a sample of 992 young-onset hypertensive patients and 992 age-and gender-matched normotensive controls selected from three Taiwan Han Chinese community studies. We separated these subjects into two subsamples for the first stage and the second stage analyses. Significant SNPs identified in the first stage was then verified at the second stage. Our goal is to identify influential genes and SNPs on these genes in Han Chinese out of these most replicable candidate genes. The findings of this study may improve screening, diagnosis, and prevention/treatment for hypertension in Han Chinese.
Methods
Study design and subjects. We designed a two-stage case-control study of young-onset hypertension (YOH). Our cases were from a total of 1023 YOH patients recruited by the Academia Sinica Multi-Centered Young-Onset Hypertension (AS-YOH) Genetic Study. 14 These patients were aged >20 years and firstly diagnosed with hypertension before age 51. Hypertension was determined if they had persistently high blood pressure (systolic blood pressure/diastolic blood pressure ≥140/90 mm Hg) or if they were on antihypertensive medications and had blood pressure (systolic blood pressure/diastolic blood pressure) ≥120/80 mm Hg in two consecutive visits within 2 months. These patients did not have severe obesity (body mass index (BMI) <35 kg/m 2 ), diabetes mellitus (fasting glucose level <126 mg/dl), and secondary causes of hypertension including chronic renal disease, renal arterial stenosis, primary aldosteronism, coarctation of the aorta, thyroid disorders, Cushing's syndrome and phenochromocytoma. All subjects were Taiwanese whose ancestors immigrated from provinces of China and their parents and grandparents have claimed that they are Han Chinese.
Among these YOH patients, only 992 patients had remained blood DNAs and were selected in the present study. We divided arbitrarily these patients into two subsamples, 400 relatively young patients (272 males and 128 females) for the first stage cases and the remaining 592 patients (411 males and 181 females) for the second stage cases. For study controls, we adopted one-to-one match strategy to select equal number of controls for age (±5 years) and sex. These controls have normal blood pressure (systolic blood pressure/diastolic blood pressure <120/80 mm Hg) and do not take any antihypertensive medication. The 400 healthy subjects for the first stage controls were selected from the Taiwan Han Chinese Cell and Genome Bank (HCCGBT). 15 The 592 healthy subjects for the second stage controls were selected from two resources, 550 subjects from the Cardiovascular Disease Risk Factor Two Township study (CVDFACTS). 16 Selections of candidate genes. To select candidate genes for hypertension, we used "hypertension" as the keyword to search for all genetic association studies regarding hypertension and hypertension related diseases in Genetic Association Database http://geneticassociationdb.nih.gov/. 13 In addition, we also took recent genome-wide association studies on hypertension into account. In total, we found 935 relevant papers for hypertensive candidate genes.
We manually reviewed each paper on genes that have been reported to be associated with hypertension and counted the number of times that each gene was reported. If a gene was repeatedly reported in the same study, we only counted it once. For our candidate gene list, we only selected genes that have been reported in more than five studies. We anticipated that genes with more reported number are likely to be replicated in the study. Many of them were in this candidate gene list. We excluded angiotensin I-converting enzyme and lipoprotein lipase genes that have been extensively studied in our group. 14, 17, 18 We also excluded angiotensin II receptor (AGTR2) gene that showed no association in our recent pooling case-control study. In total, we selected 36 candidate genes among which AGT, AGTR1, CYP11B2, GNB3, NOS3, and ADD1 have ≥20 papers recorded. These genes could be classified into five main function groups: (i) renin-angiotensinaldosterone system; (ii) messenger-related (intracellular messenger and sympathetic nervous system); (iii) channels or transporters; (iv) energy-related (energy regulation, fat and lipid regulation, glucose regulation, and steroids); and (v) others, such as circulation, cytokine, cytoskeletal, and detoxin ( Table 1) .
Selection of SNP.
We selected 238 SNPs covering 36 candidate genes according to the below criteria. Linkage disequilibrium (LD) was estimated using the 1,000 genomes databases from the HapMap project. Genotyping. We had genotyped the first stage sample of 400 YOH cases and 400 matched controls with the Illumina original contributions
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Infinium II Human Hap550 SNP chip (Illumina, San Diego, CA).This chip includes 87 selected SNPs to be investigated in the study. The rest of 151 SNPs not on the chip were additionally genotyped using Sequenom platform (Sequenom MassARRAY System, San Diego, CA). We also used this platform to genotyped the second stage sample for those SNPs that were significantly associated with hypertension at the first stage.
Statistical analysis. To ensure the SNP quality, we excluded SNPs with poor genotyping call rate (<90%) and minor allele frequency <1%. We performed the χ 2 goodness-of-fit test to check all SNPs for Hardy-Weinberg equilibrium in the case and the control groups and excluded those SNPs with P value <10 −4 . This procedure was performed for both of the two stage samples before SNP analysis. original contributions
To compare characteristics between cases and controls at the first stage, the second stage and the pooled samples, we used unpaired Student's t-test for continuous variables and the Pearson χ 2 for categorical variables. For association study, we performed conditional logistic regression under three inheritance models (additive, dominant, and recessive) in the one to one matched case-control samples. P value was estimated by Wald χ 2 -test. For discovering more potential SNPs, the significance level was defined with less stringent P value rather than P value of Bonferroni correction. SNPs with P value <0.07 in the first stage analysis were included for the second stage replication. For those SNPs with smaller P value at both stages, we pooled the two-stage samples and obtained the odd ratio and 95% confidence interval in multivariate logistic regression with adjustment for gender, age, BMI, serum total cholesterol, and serum high-density lipoprotein cholesterol. For multiple testing, we performed Bonferroni correction and false discovery rate. Furthermore, we used stratified analysis to discover potential interaction of those significant SNPs with age, BMI, and gender. These tests were performed using SAS 9.1 software (SAS Institute, Cary, NC).
results
In this study, we used 400 relatively younger YOH cases in the first stage analysis and the remaining 592 cases in the second stage analysis (mean age, 37.85 vs. 43.01). More males were in the sample, but the proportion was similar in the both stages. Table 2 shows the comparison of characteristics between cases and controls of the first stage, the second stage, and pooled samples. Although the controls were selected by matching for gender and age (within difference of 5 years) with the cases, the cases of the second stage has higher mean age than controls. BMI was significantly different between cases and controls. Table 2 also shows that cases tended to have higher serum total cholesterol and lower serum high-density lipoprotein cholesterol than controls. Table 3 shows the significantly associated SNPs with hypertension in the first stage, in the second stage and in the pooled sample. In the initial analysis, we identified 13 significant SNPs (P < 0.05) and 3 SNPs at borderline (P = 0.05-0.07). These 16 SNPs in 11 candidate genes were further genotyped in the second stage sample, and only two SNPs still appeared significantly associated with hypertension. One SNP (rs2301339) is located at guanine nucleotide-binding protein β3 subunit (GNB3) and the other SNP (rs17254521) is located at insulin receptor gene (INSR). When the two-staged samples were pooled together, the two SNPs tended to be more significant. For multiple testing, our results (see Supplementary Table  S1 online) show that rs2301339 (GNB3) is still significant (P =0.0064) and rs17254521 (INSR) is borderline significant (P = 0.0544) after adjustment for multiple testing using false discovery rate. Table 4 shows the genotype distributions and odds ratios (ORs) for the two significant SNPs in the pooled sample. The two SNPs show an additive effect with hypertension. Individuals who had more risk alleles in either rs2301339 or rs17254521 had a significantly higher risk of hypertension. After adjusting gender, age, BMI, serum total cholesterol, and serum high-density lipoprotein cholesterol, both rs2301339 SNP of GNB3 (OR = 1.43, P value = 0.0008, adjusted P value = 0.0028 for AG+GG) and rs17254521 SNP of INSR (OR = 1.27, P value = 0.0093, adjusted P value = 0.0387 for AG+GG) were still significantly associated with hypertension.
We also observed an interaction effect between rs2301339 of GNB3 and age on the risk of hypertension ( Table 5) . The positively significant result was only observed in the age group of 40-51 (OR = 2.03, P value = 1.4 × 10 −5 for AA+AG). This interaction effect was observed in both of the male and female groups (OR = 1.91 and P value = 0.0015 for the male group with AG+GG; OR = 2.25 and P value = 0.0031 for the corresponding female group).
discussion
Hypertension is a complex disease with complicated etiological causes. Despite environmental factors, a large number of genes are involved in blood pressure regulation. Interaction among genes and environmental factors, such as age and body weight, makes it difficult to detect individual gene effects. In the present study, we conducted a two-stage case-control study of YOH in Han Chinese to investigate a number of candidate genes frequently associated with hypertension. We identified SNPs in GNB3 and in INSR that are significantly associated with hypertension in both the first and second stages. Previous studies have suggested that GNB3 is correlated with hypertension, [20] [21] [22] obesity, 23,24 type 2 diabetes, 25 and stroke, 26 but the results are still controversial [27] [28] [29] [30] especially in the studies of Asian population. 28, [31] [32] [33] GNB3 encodes the β3 subunit of heterotrimetic G protein that is involved in intracellular signal transduction and regulation of protein synthesis. 34 The rs5443 SNP (known as C825T) in exon 10 was frequently studied because it was associated with an alternative splicing site (GNB3s) that causes the deletion of 41 amino acids (498-620 of exon 9) and one WD (tryptophan-aspartic acid) repeat domain of the Gβ subunit. 22 This deletion would lead to enhancement of renal tubular sodium reabsorption by increasing Na-H exchanger activity. 35 These characteristics make this polymorphism a good candidate for hypertension. However, two studies of Han Chinese populations 31, 36 focusing on the GNB3 region with more number of SNPs did not find the association of C825T but other neighboring SNPs with hypertension.
In this study, we studied rs2301339 SNP that is closed to C825T (251 base pairs distance difference) and they are in perfect LD (r 2 = 1 in the four HapMap populations). Our result shows that individuals carrying the G allele of rs2301339 SNP have a higher risk of hypertension which is opposite to the previous results and such association was only observed in the mid-age group of 40-50. Consistently, this gene-age effect was observed in both male and female groups. This result was interesting, because age is usually treated as a nuisance parameter. We showed that genetic effects of rs2301339 SNPs on hypertension vary by age and such gene-age interactions are not monotonic. It may be that the gene has operative effect later in life with accumulating effect with age. Therefore, there was different genetic effect size at different life stage. Because of the gene-age interaction and ethnic difference, the previous results for this region were less replicated and even inconsistent in the study of Han Chinese. Therefore, conducting a further study to clarify the controversial findings is necessary.
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INSR is a transmembrane receptor that consists of a tetrameric form (two α subunits and two β subunits). When insulin binds to the INSR, the receptor is phosphorylated and induces the uptake of glucose from blood. The defect in INSR may decrease INSR expression and induce insulin resistance. 37 Because hypertensive patients usually display insulin resistance, INSR is considered as an important candidate gene for hypertension. Previous studies had reported that an association of polymorphisms in intron 9 and exon 8 of INSR are associated with hypertension. 38, 39 A Chinese study suggested a mutation in exon 17 contributing to hypertension. 40 In this study, we investigated 31 SNPs across the INSR gene and identified a novel SNP of rs17254521 in intron 2 which is associated with hypertension. We did not observe any other association elsewhere in this gene.
The main limitation of this association study is its relatively small sample size. Therefore, we used multiple candidate gene approach. In hypertension genome-wide association studies with a small genotypic effect (OR ≤1.5), it is suggested to have >3,000 cases and the same number of controls in order to have reasonable power. 41 Stringent P value by Bonferroni correction may reduce the power to identify real causal SNPs and it is overly conservative when investigating SNPs are not fully independent. Therefore, adjustment for multiple testing using false discovery rate was rational in our study. In addition, population admixture and stratification could cause possible false positives. The use of multiple candidate gene approach can relax this limit.
In this study, we only selected candidate genes that had been reported in at least five publications. The study populations in these publications were not restricted to Han Chinese. It is likely that these selected genes are "older" candidate genes that have been repeatedly genotyped in the previous association studies. However, those frequently reported genes (e.g., AGT, NOS3) according to number of citation were not significant in the present study. We can anticipate that many hypertensionrelated candidate genes important to Han Chinese population might have been excluded in this study. It would be important to investigate other genes that are not included in our list in the future. We also selected the same number of young and healthy controls to be matched with the cases. Since a normotensive individual at middle age or elderly age has a 90% 42 we realized that a small proportion of potential hypertensive cases might have been misclassified into the control group, which may have compromised slightly in the statistical power. However, it is also controversial whether to use healthy controls with an elderly age, since selection bias may be introduced by survivorship of the elderly. In summary, we performed a useful method that utilized the results of the previous genetic studies in this study. This method is not out-dated and still valid in disease gene mapping. Our study had identified one novel SNP in GNB3 and one novel SNP in INSR that are strongly associated with YOH. Due to relatively small sample size, the results should still be interpreted with caution and need to be replicated in other studies. These findings may be useful for further hypertension studies in Han Chinese.
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